ecancer

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA

1 May 2014

New antibody-drug conjugate shows early promise against all forms of melanoma

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA

16 Apr 2014

Biomarker development for ipilimumab and prostate GVAX treatment

Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands

26 Mar 2014

Toll like receptor 7 agonists for cancer immunotherapy

Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany

25 Mar 2014

Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark

25 Mar 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria

25 Mar 2014

Reasons for combining immunotherapy with chemo to enhance anti tumour response

Prof Angus Dalgleish - St George's, University of London, London, UK

25 Mar 2014

Dendritic cell vaccination combined with CTLA4 blockade

Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium

25 Mar 2014

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

12 Feb 2014

Where to next for the elderly with acute myeloid leukaemia?

Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands

19 Dec 2013

2013 ecancermedicalscience article highlights

Prof Gordon McVie - ecancer and European Institute of Oncology

11 Dec 2013

Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL

Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA

$Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )$

8 Dec 2013

More from ecancer